This inventor holds 4 USPTO granted patents. Top assignees: Intercell Ag, Valneva Austria Gmbh. Active years: 2008-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2015
Title: Sabine Kallenda: Innovator in Nucleic Acid Technologies
Introduction
Sabine Kallenda is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of biotechnology, particularly in the development of nucleic acid technologies. With a total of 4 patents to her name, her work has had a substantial impact on medical research and applications.
Latest Patents
Her latest patents focus on isolated nucleic acid molecules that encode hyperimmune serum reactive antigens. These inventions include methods for isolating such antigens and their specific uses, showcasing her innovative approach to addressing complex biological challenges.
Career Highlights
Throughout her career, Sabine has worked with notable companies such as Intercell AG and Valneva Austria GmbH. Her experience in these organizations has allowed her to refine her expertise and contribute to groundbreaking research in her field.
Collaborations
Sabine has collaborated with esteemed colleagues, including Andreas Meinke and Eszter Nagy. These partnerships have further enhanced her research capabilities and fostered a collaborative environment for innovation.
Conclusion
Sabine Kallenda's contributions to biotechnology and her innovative patents highlight her role as a leading inventor in her field. Her work continues to influence advancements in medical research and applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile